Article

Bbarrons.com on 2019-11-27 18:12

BioMarin Stock Jumps on Analyst Upgrade

Barclays analyst says the market is underestimating the value of the BioMarin’s experimental gene therapies for hemophilia A and achondoplasia. Its ...

Related news

BBioMarin Stock Jumps as Analyst Calls Doubts Over Hemophilia Drug ‘Overblown’barrons.com
Phase 2
BBioMarin Stock Rises on Earnings Beat barrons.com
Europe
BBioMarin Drops After Hours on Weak Earnings barrons.com
Europe , Wall Street , Arén
MTwitter's stock jumps after analyst upgrade marketwatch.com
MNike's stock jumps, to pace Dow gainers after analyst upgrade marketwatch.com
Rio de Janeiro
MBank of America's stock jumps, as analyst upgrade fuels bounce marketwatch.com
China
BLowe’s Stock Rises on Analyst Upgrade barrons.com
Stock Island
BModerna Stock Jumps on Coronavirus Vaccine Progress barrons.com
Stock Island , Norwood , China , Hubei
BCigna Stock Rises on Analyst's Bullish Upgrade barrons.com
Washington , Stock Island
Cullen/Frost gets analyst upgrade on improved oil outlook bizjournals.com
BRegeneron Stock Jumps After Analyst Says Now Could Be a Good Time to Buy barrons.com
Coney Island
MSnap stock jumps after analyst suggests says 'the worst is behind' it marketwatch.com
BSnowflake Stock Gets Another Upgrade. Why an Analyst Sees a Buying Opportunity.1 min read barrons.com
Wall Street
BBeyond Meat Stock Gets a Double Upgrade. Analyst Think It's Undervalued. 1 min read barrons.com
MWynn Resorts stock jumps 3.3% to lead S&P 500 gainers after Barclays upgrade marketwatch.com
Macau
After A Healthy Correction Can BioMarin Stock Offer Any Upside?Forbes
China
MPfizer's stock jumps to 13-month high to lead Dow gainers after analyst upgrade marketwatch.com
MConn's stock jumps toward 21-month high after an analyst upgrade marketwatch.com
MHasbro's stock jumps after analyst upgrade ahead of Star Wars toys launch marketwatch.com